Alisdair Ryding

ORCID: 0000-0003-3549-8761
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Peripheral Artery Disease Management
  • Atherosclerosis and Cardiovascular Diseases
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Structural Anomalies and Repair
  • Cardiac Valve Diseases and Treatments
  • Hemodynamic Monitoring and Therapy
  • Cardiovascular Function and Risk Factors
  • Cardiac Arrest and Resuscitation
  • Hormonal Regulation and Hypertension
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cerebrovascular and Carotid Artery Diseases
  • Advanced MRI Techniques and Applications
  • Cardiomyopathy and Myosin Studies
  • Healthcare Systems and Practices
  • ECG Monitoring and Analysis
  • Mechanical Circulatory Support Devices
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cell Adhesion Molecules Research
  • Heart Failure Treatment and Management
  • Cardiovascular and Diving-Related Complications
  • Aortic aneurysm repair treatments

Norfolk and Norwich University Hospital
2016-2025

Norfolk and Norwich University Hospitals NHS Foundation Trust
2019-2024

Clinical Trial Investigators
2022

University of East Anglia
2017-2022

Queen Mary University of London
2022

Norwich Research Park
2021

James Paget University Hospital
2014

Westmead Hospital
2008-2009

John Radcliffe Hospital
2007-2008

University of Manchester
2005

Derek J. Hausenloy Rajesh Kharbanda Ulla Møller Manish Ramlall Jens Aarøe and 95 more Robert J. Butler Heerajnarain Bulluck Tim Clayton Ali Dana Matthew Dodd Thomas Engstrøm Richard D. Evans Jens Flensted Lassen Erika Frischknecht Christensen José M. García‐Ruiz Diana A Gorog Jakob Hjort R. Houghton Borja Ibáñez Rosemary Knight Freddy Lippert Jacob Thomsen Lønborg Michael Mæng Dejan Milasinovic Ranjit More Jennifer M. Nicholas Lisette Okkels Jensen Alexander Perkins Nebojša Radovanović Roby Rakhit Jan Ravkilde Alisdair Ryding Michael Rahbek Schmidt Ingunn S. Riddervold Henrik Toft Sørensen Goran Stanković Madhusudhan Varma Ian Webb Christian Juhl Terkelsen John P. Greenwood Derek M. Yellon Hans Erik Bøtker Anders Junker Anne Kaltoft Morten Madsen Evald Høj Christiansen Lars Jakobsen Steen Carstensen Steen Dalby Kristensen Troels Thim Karen E. Pedersen Marianne Korsgaard Allan Iversen Erik Jørgensen Francis R. Joshi Frants Pedersen Hans Henrik Tilsted Karam Alzuhairi Kari Saunamäki Lene Holmvang Ole Ahlehof Rikke Sørensen Steffen Helqvist B. Màrk Anton Boel Villadsen Bent Raungaard Leif Thuesen M. Christiansen Phillip Freeman Svend Eggert Jensen Charlotte Schmidt Skov Ahmed Aziz Henrik Hansen Julia Ellert Karsten Tange Veien Knud Erik Pedersen Knud Hansen Ole Ahlehoff Helle Cappelen Daniel Wittrock Poul Anders Hansen Jens Peter Ankersen Kathryn Hedegaard John Kempel Henning Kaus Dennis Erntgaard Henrik D. Pedersen Matthias Giebner Troels Martin Hansen Mina Radovanović Maja Prodanović Lidija Savić Marijana Pejic Dragan Matić Ana Ušćumlić Ida Subotić Ratko Lasica Vladan Vukcevic Alfonso Suárez Beatriz Samaniego

BackgroundRemote ischaemic conditioning with transient ischaemia and reperfusion applied to the arm has been shown reduce myocardial infarct size in patients ST-elevation infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). We investigated whether remote could incidence of cardiac death hospitalisation for heart failure at 12 months.MethodsWe did an international investigator-initiated, prospective, single-blind, randomised controlled trial (CONDI-2/ERIC-PPCI) 33...

10.1016/s0140-6736(19)32039-2 article EN cc-by The Lancet 2019-09-06

Older people increasingly constitute a large proportion of the acute coronary syndrome (ACS) population. We examined relationship age with receipt more intensive management and secondary prevention medicine. Then, comparative association (reperfusion/angiography) over conservative strategy on time to death was investigated by age. Using data from 155 818 patients in national registry for ACS England Wales [the Myocardial Ischaemia National Audit Project (MINAP)], we found that older were...

10.1093/eurheartj/ehu039 article EN European Heart Journal 2014-03-18

The objective of this study is to compare the outcomes patients treated with drug-coated balloons (DCBs) or second-generation drug-eluting stents (DESs) for de novo unprotected left main stem (LMS) disease. Previous studies comparing treatment LMS disease suggest that mortality DES PCI not worse than CABG. There are limited data from investigating DCB angioplasty. We compared all-cause and cardiac paclitaxel those July 2014 November 2019. Data were analysed using Kaplan–Meier analyses...

10.3390/jcdd10020084 article EN cc-by Journal of Cardiovascular Development and Disease 2023-02-16

Plaque erosion causes 30% of ST-segment elevation myocardial infarctions, but the underlying cause is unknown. Inflammatory infiltrates are less abundant in compared with rupture autopsy studies. We hypothesized that and associated significant differences intracoronary cytokines vivo.Forty infarction patients <6 hours chest pain were classified as ruptured fibrous cap (RFC) or intact (IFC) using optical coherence tomography. Plasma samples from infarct-related artery a peripheral analyzed...

10.1161/jaha.117.005868 article EN cc-by-nc-nd Journal of the American Heart Association 2017-05-04

Abstract Objectives We aimed to investigate long-term survival of paclitaxel DCB for percutaneous coronary intervention (PCI). Background Safety concerns have been raised over the use devices peripheral artery disease recently, following a meta-analysis suggesting increased late mortality. With regard drug-coated balloon (DCB) angioplasty however, there is limited data date regarding possible mortality relating paclitaxel. Methods compared all-cause patients treated with those non-paclitaxel...

10.1007/s00392-020-01734-6 article EN cc-by Clinical Research in Cardiology 2020-09-02
Domingo A. Pascual‐Figal Rolf Wachter Michele Senni Weibin Bao Adele Noè and 95 more H. Schwende Dmytro Butylin Margaret F. Prescott Jacek Gniot М Е Можейко Małgorzata Lelonek A. Reyes Domínguez Thomas Horacek Enrique Garcia del Rio Zhanna Kobalava Christian Mueller Yüksel Çavuşoğlu Ewa Straburzyńska−Migaj Miroslav Slanina Juergen vom Dahl Michele Senni Alisdair Ryding Andrew Moriarty Manuel Beltrán Robles Julio Núñez Antonio García Quintana Thorsten Nitschke José Manuel García Pinilla Luis Almenar Bonet Said Chaaban Samia Filali zaatari Jindřich Špinar Włodzimierz J. Musiał Khaled Abdelbaki Jan Bělohlávek Wolfgang Fehske Michael Carlos Bott Geir Hoegalmen Marisa Crespo Leiro İsmail Türkay Özcan Wilfried Müllens Radim Kryza Riadh Al‐Ani Krystyna Łoboz‐Grudzień Lyudmila Ermoshkina Silvia Hojerova Alberto Alfredo Fernandez Lenka Špinarová Harald Lapp Efraim Bulut Filipa Almeida A. A. Vishnevsky Margita Belicová Domingo A. Pascual‐Figal Klaus K. Witte Kenneth Wong Walter Droogné Marc Delforge Martin Peterka Hans‐Georg Olbrich Stefano Carugo Jadwiga Nessler Thao Huynh McGill Burkhard Huegl İbrahim Akın Ilídio Moreira А. Н. Багликов Jeetendra Thambyrajah Chris Hayes Marcelo Barrionuevo Zerrin Yiğit Hakkı Kaya Zdeněk Klimsa Martin Radvan C Kadel Ulf Landmesser Giuseppe Di Tano Malgorzata Buksinska Lisik Cândida Fonseca Luís Oliveira Irene Marques Luís M.G. Santos Egon Lenner Peter Letavay Manuel Gómez‐Bueno Paula Mota Aaron Wong Kristian Bailey Paul Foley Eduardo Hasbani Sean Virani Tony Abdel Massih Shukri AlSaif Miloš Táborský Marta Kaislerova Zuzana Moťovská Aron Ariel Cohen Damien Logeart Dierk Endemann Daniel Ferreira

This study examined the effects of sacubitril/valsartan on N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels and determined patient characteristics associated with favorable NT-proBNP reduction response. reflect cardiac wall stress predict event risk in patients acute decompensated heart failure (ADHF). Post-hoc analysis TRANSITION (Comparison Pre- Post-discharge Initiation Sacubitril/Valsartan Therapy HFrEF Patients After an Acute Decompensation Event) study, including stabilized...

10.1016/j.jchf.2020.05.012 article EN cc-by-nc-nd JACC Heart Failure 2020-08-12

Human essential hypertension is characterized by eutrophic remodeling of small arteries, with little evidence hypertrophy. Likewise, vessels young hypertensive TGR(mRen2)27 animals have undergone similar structural alterations. The role integrins in resistance arteries during the eutrophic-remodeling process was examined as blood pressure rose. Initially, 8 alpha and 3 beta were identified levels expression investigated using RT-PCR. As increased advanced, integrin profiles revealed that...

10.1161/01.hyp.0000198428.45132.02 article EN Hypertension 2005-12-28

Background: There are no data regarding the outcomes of patients with stent thrombosis (ST) being treated drug-coated balloon (DCB) angioplasty. Our aim was to compare ST DCB vs. a drug eluting (DES). Methods: In this registry analysis, we identified all for in our institution from June 2011 until November 2019. We excluded who died cath lab, uncrossable lesions, and thrombectomy only. Patient were obtained Hospital Episodes Statistics NHS England. The primary endpoint study composite...

10.3390/jcdd12020059 article EN cc-by Journal of Cardiovascular Development and Disease 2025-02-05

ABSTRACT Background and Aims A randomized trial has previously demonstrated that neointimal modification with a scoring balloon improves the anti‐restenotic effect of drug‐coated (DCB) in patients drug‐eluting stent restenosis. There are very limited data about safety efficacy using balloons as part lesion preparation STEMI, especially de novo disease treated DCB‐only angioplasty. Methods We undertook an analysis SPARTAN Norwich Registry to address this question. compared composite endpoint...

10.1002/hsr2.70839 article EN cc-by Health Science Reports 2025-05-01

Abstract Background Measurement of peak velocities is important in the evaluation heart failure. This study compared performance automated 4D flow cardiac MRI (CMR) with traditional transthoracic Doppler echocardiography (TTE) for measurement mitral inflow diastolic velocities. Methods Patients and magnetic resonance data were included retrospectively. An established technique was used to segment left ventricular transvalvular using short-axis cine stack images. Peak E-wave A-wave...

10.1186/s12872-023-03052-x article EN cc-by BMC Cardiovascular Disorders 2023-01-16

Platypnea orthodeoxia is a rare syndrome that describes breathlessness on standing resolves lying flat. We present previously healthy patient who developed platypnea in her eighth decade of life. Cardiovascular imaging demonstrated an atrial septal defect, extensive Chiari network and hypertrophy. propose the development lipomatous hypertophy led to altered compliance baffle direct flow preferentially left heart standing.

10.1093/ejechocard/jen015 article EN European Heart Journal - Cardiovascular Imaging 2008-02-20

Aortic conduit and reservoir functions can be directly measured by four-dimensional flow (4D flow) cardiovascular magnetic resonance (CMR).

10.1136/openhrt-2024-002713 article EN cc-by-nc-nd Open Heart 2024-08-01

A 67-year-old cachectic patient presented with a 6-week history of increasing breathlessness, loss weight and appetite. Examination showed peripheral oedema signs cardiac tamponade. Transthoracic echocardiography demonstrated thick walled cystic mass in the anterior pericardium (see online supplementary video 1), compressing right ventricle (RV) atrium (RA). Further evaluation, including bubble contrast echocardiography, suggested haematogenous connection between RA tumour cavity 2). This...

10.1136/heartjnl-2013-303813 article EN Heart 2013-06-13
Coming Soon ...